Filter
218
Text search:
biologicals
Featured
Recommendations
23
New Publications
45
Language
Document type
No document type
83
Guidelines
51
Studies & Reports
36
Manuals
20
Strategic & Response Plan
19
Fact sheets
5
Training Material
2
Brochures
1
Resource Platforms
1
Countries / Regions
Global
14
India
12
Western and Central Europe
7
Philippines
5
Nigeria
4
Germany
3
Kenya
3
South Africa
3
Latin America and the Carribbean
3
Africa
3
Ethiopia
2
Uganda
2
Zimbabwe
2
Nepal
2
Tanzania
2
Rwanda
2
Argentina
2
Botswana
2
South–East Asia Region
2
Paraguay
2
Sierra Leone
1
Liberia
1
Ghana
1
Cambodia
1
Thailand
1
Bangladesh
1
Malawi
1
Namibia
1
Peru
1
Eswatini/ Swaziland
1
Brazil
1
Ukraine
1
Colombia
1
Ecuador
1
Bolivia
1
Madagascar
1
Myanmar / Burma
1
Chile
1
Eastern Europe and Central Asia
1
Venezuela
1
Russia
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
52
Countries
48
Women & Child Health
30
Key Resources
12
Public Health
10
Pharmacy & Technologies
8
Capacity Building
3
Toolboxes
Pharmacy
26
COVID-19
20
Rapid Response
14
TB
12
NTDs
11
HIV
10
2.0 Rapid Response
9
AMR
7
Malaria
7
Polio
5
Planetary Health
5
Refugee
4
Ebola & Marburg
3
Cholera
3
Conflict
3
Natural Hazards
3
Mental Health
3
Zika
2
Global Health Education
1
Caregiver
1
NCDs
1
This document is intended to serve as a reference for national public health policy-makers. It outlines the scope of potential meningitis surveillance strategies that make it possible to obtain the data required for epidemic detection, monitoring of epidemiological and microbiological trends, evalua
...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method
...
This publication gives a broad vision of what a comprehensive approach to cervical cancer prevention and control means. In particular, it outlines the complementary strategies for comprehensive cervical cancer prevention and control, and highlights the neners. This new guide updates the 2006 edition
...
WHO technical advisory group on behavioural insights and sciences for health, meeting report, 15 October 2020
The new WHO recommendations for rabies immunization supersede the 2010 WHO position
on pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) for rabies. These updated
recommendations are based on new evidence and directed by public health needs that are cost-,
dose- and time-sparing
...
The World Health Organization provides regional and national strategies and operational plans that aim to support countries in work to achieve measles control and elimination. These are guided by high level frameworks including the Immunization Agenda 2030 and the Measles and Rubella Strategic Frame
...
Technical document, update 2021
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt
...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi
...
Cervical cancer is the fourth most common cancer in women worldwide in 2018, with 570,000 new cases and 311,000 deaths occurring annually.T he highest incidence rates are in Southern Africa, Eastern Africa, SubSaharan Africa, Western Africa, Melanesia, and Middle Africa . It also ranks as the leadin
...
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resistance and lead to loss of confidence in health prof
...
Risk assessment and priority interventions
Preferred product characteristics and clinical development considerations
